Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Acetylsalicylic Acid / / Karsten Schrör
| Acetylsalicylic Acid / / Karsten Schrör |
| Autore | Schrör Karsten |
| Edizione | [Third edition.] |
| Pubbl/distr/stampa | Berlin : , : De Gruyter, , 2022 |
| Descrizione fisica | 1 online resource (vii, 623 pages) |
| Disciplina | 615.19 |
| Soggetto topico | Pharmaceutical chemistry |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910629590103321 |
Schrör Karsten
|
||
| Berlin : , : De Gruyter, , 2022 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Acetylsalicylic acid / / Karsten Schrör
| Acetylsalicylic acid / / Karsten Schrör |
| Autore | Schrör Karsten |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2016 |
| Descrizione fisica | 1 online resource (477 p.) |
| Disciplina | 854.914080356 |
| Soggetto topico | Aspirin |
| ISBN |
3-527-68504-9
3-527-68502-2 3-527-68505-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Acetylsalicylic Acid; Contents; Preface; 1: General Aspects; 2: Pharmacology; 3: Toxicity and Drug Safety; 4: Clinical Applications of Aspirin; Appendix 1: Abbreviations; Appendix 2: Selected Clinical Trials and Their Acronyms - Only Published Trials; Index; End User License Agreement; 1.1 History; 1.2 Chemistry; 2.1 Pharmacokinetics; 2.2 Cellular Modes of Action; 2.3 Actions on Organs and Tissues; 3.1 Systemic Side Effects; 3.2 Organ Toxicity; 3.3 Hypersensitivity to Aspirin and Reye's Syndrome; 4.1 Thromboembolic Diseases; 4.2 Pain, Fever, and Inflammatory Diseases
4.3 Further Potential Clinical Indications1.1.1 From Willow Bark to Salicylic Acid; 1.1.2 Synthesis of Acetylated Salicylic Acid and First Medical Use; 1.1.3 Search for Pharmacological Modes of Action; 1.1.4 Clinical Applications: A Piece of History; 1.1.5 Current Research Topics; 1.2.1 Structures and Chemical Properties of Salicylates; 1.2.2 Determination of Salicylates; 2.1.1 Absorption and Distribution; 2.1.2 Biotransformation and Excretion; 2.2.1 Inhibition of Cyclooxygenases; 2.2.2 COX-Independent Actions of Aspirin on Cell Function; 2.2.3 Energy Metabolism 2.3.1 Hemostasis and Thrombosis2.3.2 Inflammation, Pain, and Fever; 2.3.3 Aspirin and Malignancies; 3.1.1 Acute and Chronic Toxicity; 3.1.2 Bleeding Time and Bleeding Risk; 3.1.3 Safety Pharmacology in Particular Life Situations; 3.2.1 Gastrointestinal (GI) Tract; 3.2.2 Liver; 3.2.3 Kidney; 3.2.4 Audiovestibular System; 3.3.1 Aspirin-Exacerbated Respiratory Disease (AERD, ""Aspirin-Induced Asthma""); 3.3.2 Urticaria/Angioedema and Stevens-Johnson and Lyell's Syndrome; 3.3.3 Reye's Syndrome; 4.1.1 Coronary Vascular Disease; 4.1.2 Cerebrovascular Diseases; 4.1.3 Peripheral Arterial Disease 4.1.4 Venous Thrombosis4.1.5 Preeclampsia; 4.1.6 Aspirin ``Resistance ́́(High On-Aspirin Treatment Platelet Reactivity); 4.2.1 Analgesia and Antipyresis; 4.2.2 Inflammatory Diseases; 4.2.3 Kawasaki's Disease; 4.3.1 Colorectal Cancer; 4.3.2 Alzheimer's Disease; 1.1.1.1 Anti-Inflammatory and Analgesic Effects of Willow Bark and Leaves; 1.1.1.2 Salicylates as the Active Ingredients of Willow Bark and Other Natural Sources; 1.1.1.3 Chemical Synthesis of Salicylic Acid; Summary; References; 1.1.2.1 The Invention of Acetylated Salicylic Acid 1.1.2.2 Introduction of Acetylsalicylic Acid into the ClinicsSummary; References; 1.1.3.1 Salicylates and Energy Metabolism of the Cell; 1.1.3.2 Aspirin and Prostaglandin Formation; 1.1.3.3 Aspirin and COX-2; Summary; References; 1.1.4.1 Anti-Inflammatory/Analgesic Actions; 1.1.4.2 Antiplatelet/Antithrombotic Actions and the Bleeding Tendency; 1.1.4.3 Aspirin and the History of Prevention of Myocardial Infarction and Stroke; Summary; References; 1.1.5.1 Clinical Research; 1.1.5.2 Basic Research; Summary; References; 1.2.1.1 Salicin: The Natural Salicylate; 1.2.1.2 Salicylates in Clinical Use 1.2.1.3 Aspirin Formulations |
| Record Nr. | UNINA-9910134856403321 |
|
Schrör Karsten
|
||
| Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Acetylsalicylic acid / / Karsten Schrör
| Acetylsalicylic acid / / Karsten Schrör |
| Autore | Schrör Karsten |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2016 |
| Descrizione fisica | 1 online resource (477 p.) |
| Disciplina | 854.914080356 |
| Soggetto topico | Aspirin |
| ISBN |
3-527-68504-9
3-527-68502-2 3-527-68505-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Acetylsalicylic Acid; Contents; Preface; 1: General Aspects; 2: Pharmacology; 3: Toxicity and Drug Safety; 4: Clinical Applications of Aspirin; Appendix 1: Abbreviations; Appendix 2: Selected Clinical Trials and Their Acronyms - Only Published Trials; Index; End User License Agreement; 1.1 History; 1.2 Chemistry; 2.1 Pharmacokinetics; 2.2 Cellular Modes of Action; 2.3 Actions on Organs and Tissues; 3.1 Systemic Side Effects; 3.2 Organ Toxicity; 3.3 Hypersensitivity to Aspirin and Reye's Syndrome; 4.1 Thromboembolic Diseases; 4.2 Pain, Fever, and Inflammatory Diseases
4.3 Further Potential Clinical Indications1.1.1 From Willow Bark to Salicylic Acid; 1.1.2 Synthesis of Acetylated Salicylic Acid and First Medical Use; 1.1.3 Search for Pharmacological Modes of Action; 1.1.4 Clinical Applications: A Piece of History; 1.1.5 Current Research Topics; 1.2.1 Structures and Chemical Properties of Salicylates; 1.2.2 Determination of Salicylates; 2.1.1 Absorption and Distribution; 2.1.2 Biotransformation and Excretion; 2.2.1 Inhibition of Cyclooxygenases; 2.2.2 COX-Independent Actions of Aspirin on Cell Function; 2.2.3 Energy Metabolism 2.3.1 Hemostasis and Thrombosis2.3.2 Inflammation, Pain, and Fever; 2.3.3 Aspirin and Malignancies; 3.1.1 Acute and Chronic Toxicity; 3.1.2 Bleeding Time and Bleeding Risk; 3.1.3 Safety Pharmacology in Particular Life Situations; 3.2.1 Gastrointestinal (GI) Tract; 3.2.2 Liver; 3.2.3 Kidney; 3.2.4 Audiovestibular System; 3.3.1 Aspirin-Exacerbated Respiratory Disease (AERD, ""Aspirin-Induced Asthma""); 3.3.2 Urticaria/Angioedema and Stevens-Johnson and Lyell's Syndrome; 3.3.3 Reye's Syndrome; 4.1.1 Coronary Vascular Disease; 4.1.2 Cerebrovascular Diseases; 4.1.3 Peripheral Arterial Disease 4.1.4 Venous Thrombosis4.1.5 Preeclampsia; 4.1.6 Aspirin ``Resistance ́́(High On-Aspirin Treatment Platelet Reactivity); 4.2.1 Analgesia and Antipyresis; 4.2.2 Inflammatory Diseases; 4.2.3 Kawasaki's Disease; 4.3.1 Colorectal Cancer; 4.3.2 Alzheimer's Disease; 1.1.1.1 Anti-Inflammatory and Analgesic Effects of Willow Bark and Leaves; 1.1.1.2 Salicylates as the Active Ingredients of Willow Bark and Other Natural Sources; 1.1.1.3 Chemical Synthesis of Salicylic Acid; Summary; References; 1.1.2.1 The Invention of Acetylated Salicylic Acid 1.1.2.2 Introduction of Acetylsalicylic Acid into the ClinicsSummary; References; 1.1.3.1 Salicylates and Energy Metabolism of the Cell; 1.1.3.2 Aspirin and Prostaglandin Formation; 1.1.3.3 Aspirin and COX-2; Summary; References; 1.1.4.1 Anti-Inflammatory/Analgesic Actions; 1.1.4.2 Antiplatelet/Antithrombotic Actions and the Bleeding Tendency; 1.1.4.3 Aspirin and the History of Prevention of Myocardial Infarction and Stroke; Summary; References; 1.1.5.1 Clinical Research; 1.1.5.2 Basic Research; Summary; References; 1.2.1.1 Salicin: The Natural Salicylate; 1.2.1.2 Salicylates in Clinical Use 1.2.1.3 Aspirin Formulations |
| Record Nr. | UNINA-9910830373403321 |
|
Schrör Karsten
|
||
| Weinheim, Germany : , : Wiley-VCH Verlag GmbH & Co. KGaA, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||